Latest News about PFE
Recent news which mentions PFE
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
September 23, 2024
From Benzinga
2 Beaten-Down Stocks to Buy and Hold for a Decade
September 23, 2024
From Motley Fool
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
From Benzinga
3 Dirt Cheap Stocks to Buy Right Now
September 21, 2024
From Motley Fool
Pfizer Advances On Its Cancer Journey
September 20, 2024
From Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
September 20, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
From Benzinga
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
September 18, 2024
From Benzinga
From Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
September 18, 2024
From Motley Fool
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
September 17, 2024
From Motley Fool
Intel, Microsoft, Meta Platforms, Pfizer, Tesla: Why These 5 Stocks Are On Investors' Radars Today
September 16, 2024
From Benzinga
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
September 16, 2024
Tickers
PFE
From Motley Fool
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
From Benzinga
Got $5,000? 3 Dirt Cheap Stocks to Buy Right Now
September 13, 2024
From Motley Fool
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
From Motley Fool
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
September 13, 2024
From Motley Fool
From Benzinga
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
September 11, 2024
From Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
From Motley Fool
2 Beaten-Down Stocks That Could Be Great Buys on the Dip
September 11, 2024
From Motley Fool
3 High-Yield Stocks to Buy Hand Over Fist in September
September 10, 2024
From Motley Fool
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
From Benzinga
Why Is Moderna Stock Trading Higher On Monday?
September 09, 2024
From Benzinga
Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
September 09, 2024
From Benzinga
3 No-Brainer Dividend Stocks With Yields Above 5% You Can Buy Now and Hold at Least a Decade
September 09, 2024
From Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
September 08, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.